
Transcat, Inc. (NASDAQ:TRNS – Free Report) – Equities researchers at Northland Securities boosted their FY2029 EPS estimates for shares of Transcat in a research report issued on Tuesday, January 20th. Northland Securities analyst E. Jackson now anticipates that the scientific and technical instruments company will earn $2.96 per share for the year, up from their prior forecast of $2.95. Northland Securities currently has a “Strong-Buy” rating on the stock. The consensus estimate for Transcat’s current full-year earnings is $2.30 per share. Northland Securities also issued estimates for Transcat’s FY2030 earnings at $3.51 EPS.
Transcat (NASDAQ:TRNS – Get Free Report) last released its quarterly earnings data on Monday, November 3rd. The scientific and technical instruments company reported $0.44 earnings per share for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.02). Transcat had a net margin of 3.75% and a return on equity of 6.81%. The business had revenue of $82.27 million during the quarter, compared to analysts’ expectations of $79.51 million.
Get Our Latest Research Report on TRNS
Transcat Trading Up 2.2%
Shares of TRNS stock opened at $64.14 on Thursday. The company has a market capitalization of $598.43 million, a PE ratio of 52.57 and a beta of 0.78. Transcat has a 52-week low of $50.23 and a 52-week high of $106.03. The business’s fifty day moving average is $57.89 and its 200 day moving average is $70.05. The company has a debt-to-equity ratio of 0.38, a quick ratio of 2.06 and a current ratio of 2.43.
Institutional Trading of Transcat
A number of hedge funds and other institutional investors have recently modified their holdings of TRNS. Conestoga Capital Advisors LLC grew its position in shares of Transcat by 13.7% during the 2nd quarter. Conestoga Capital Advisors LLC now owns 1,088,471 shares of the scientific and technical instruments company’s stock valued at $93,565,000 after acquiring an additional 131,217 shares during the period. Bessemer Group Inc. increased its position in Transcat by 35.8% in the second quarter. Bessemer Group Inc. now owns 244,491 shares of the scientific and technical instruments company’s stock worth $21,016,000 after buying an additional 64,422 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Transcat by 1.8% in the second quarter. Geode Capital Management LLC now owns 223,202 shares of the scientific and technical instruments company’s stock worth $19,189,000 after buying an additional 4,030 shares during the period. Atria Investments Inc purchased a new position in shares of Transcat during the 2nd quarter valued at about $259,000. Finally, Truist Financial Corp bought a new position in shares of Transcat during the 2nd quarter valued at approximately $318,000. 98.34% of the stock is owned by hedge funds and other institutional investors.
Transcat Company Profile
Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.
In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.
Featured Stories
- Five stocks we like better than Transcat
- The Government Prints Trillions. Silver Supply Is Limited.
- Your Signature Is Missing – Act Before It’s Too Late
- Wall Street Alert: Buy AES
- Trump Did WHAT??
- Refund From 1933: Trump’s Reset May Create Instant Wealth
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.
